Q: We have a patient admitted for COVID-19 who is now showing signs of cytokine release syndrome (CRS). Can you give our team more information on symptoms or clinical indicators for CRS as well as any ICD-10-CM coding advice?
Q: We have heard that Medicare short-stay inpatient admissions may soon come under increasing audit scrutiny by Livanta, the Beneficiary and Family-Centered Care Quality Improvement Organizations that was awarded the nationwide contract for reviewing these admissions. What can we do to reduce our audit risk?
Q: Is it considered a HIPAA violation for facilities to keep patient charts outside of exam rooms or at a patient's bedside? Most providers prefer to have the charts handy to review just before seeing the patient. However, anyone could walk by the room and potentially get a glance at the information. Would this be considered an incidental disclosure?
Q: We had a patient admitted with a negative COVID-19 test, but after being retested the patient had a positive COVID-19 result. Should we query the provider whether COVID-19 was POA?
Q: If an individual provides authorization for a disclosure, can the individual later revoke the authorization? Is the covered entity (CE) then required to “take back” or demand the erasure of any documentation by third parties that may have been made following the original authorization?
